171 related articles for article (PubMed ID: 3872844)
21. Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia.
Shenep JL; Munson RS; Barenkamp SJ; Granoff DM
Infect Immun; 1983 Oct; 42(1):257-63. PubMed ID: 6604698
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lungs.
Gaschler GJ; Zavitz CC; Bauer CM; Stämpfli MR
Eur Respir J; 2010 Nov; 36(5):1131-42. PubMed ID: 20413532
[TBL] [Abstract][Full Text] [Related]
23. Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats.
Kauppi M; Saarinen L; Käyhty H
J Infect Dis; 1993 Feb; 167(2):365-71. PubMed ID: 8421170
[TBL] [Abstract][Full Text] [Related]
24. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.
Jelonek MT; Chang SJ; Chiu CY; Park MK; Nahm MH; Ward JI
Infect Immun; 1993 Dec; 61(12):5345-50. PubMed ID: 8225608
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to Haemophilus influenzae type b polysaccharide affect bacterial adherence and multiplication.
van Alphen L; Eijk P; Käyhty H; van Marle J; Dankert J
Infect Immun; 1996 Mar; 64(3):995-1001. PubMed ID: 8641812
[TBL] [Abstract][Full Text] [Related]
26. Haemophilus influenzae type b immunization in infants on peritoneal dialysis. Pediatric Peritoneal Dialysis Study Consortium.
Neu AM; Lederman HM; Warady BA; Fivush BA
Pediatr Nephrol; 1996 Feb; 10(1):84-5. PubMed ID: 8611367
[TBL] [Abstract][Full Text] [Related]
27. Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection.
Gibb D; Giacomelli A; Masters J; Spoulou V; Ruga E; Griffiths H; Kroll S; Giaquinto C; Goldblatt D
Pediatr Infect Dis J; 1996 Dec; 15(12):1097-101. PubMed ID: 8970219
[TBL] [Abstract][Full Text] [Related]
28. Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.
Marks MI; Ziegler EJ; Douglas H; Corbeil LB; Braude AI
J Clin Invest; 1982 Apr; 69(4):742-9. PubMed ID: 7042755
[TBL] [Abstract][Full Text] [Related]
29. Paradoxical effect of pilus expression on binding of antibodies by Haemophilus influenzae.
Gilsdorf JR; Tucci M; Forney LJ; Watson W; Marrs CF; Hansen EJ
Infect Immun; 1993 Aug; 61(8):3375-81. PubMed ID: 7687585
[TBL] [Abstract][Full Text] [Related]
30. Passive immunization for the prevention of otitis media.
Englund JA; Glezen WP
Vaccine; 2000 Dec; 19 Suppl 1():S116-21. PubMed ID: 11163474
[TBL] [Abstract][Full Text] [Related]
31. Mucosal antibodies to Haemophilus influenzae type b capsular polysaccharide.
Gilsdorf JR; McDonnell WM
Pediatr Res; 1991 May; 29(5):420-3. PubMed ID: 1896245
[TBL] [Abstract][Full Text] [Related]
32. Role of C5 and recruited neutrophils in early clearance of nontypable Haemophilus influenzae from murine lungs.
Toews GB; Vial WC; Hansen EJ
Infect Immun; 1985 Oct; 50(1):207-12. PubMed ID: 3876284
[TBL] [Abstract][Full Text] [Related]
33. A minor high-molecular-weight outer membrane protein of Haemophilus influenzae type b is a protective antigen.
Kimura A; Gulig PA; McCracken GH; Loftus TA; Hansen EJ
Infect Immun; 1985 Jan; 47(1):253-9. PubMed ID: 2578121
[TBL] [Abstract][Full Text] [Related]
34. Invasive Haemophilus influenzae type b (Hib) infection in an adult patient with a selective deficiency of antibody to the Hib capsular polysaccharide.
Follin P; Ulanova M; Hahn-Zoric M; Hanson LA
Clin Infect Dis; 1997 Oct; 25(4):915-7. PubMed ID: 9356808
[TBL] [Abstract][Full Text] [Related]
35. Vaccine-induced human antibody responses to the Haemophilus influenzae b polysaccharide in severe combined immunodeficient mice engrafted with human leukocytes.
Lucas AH; Siff TE; Trujillo KH; Kitamura MY
Pediatr Res; 1992 Jul; 32(1):132-5. PubMed ID: 1635839
[TBL] [Abstract][Full Text] [Related]
36. Immunoprotection of rats against Haemophilus influenzae type B disease mediated by monoclonal antibody against a haemophilus outer-membrane protein.
Hansen EJ; Robertson SM; Gulig PA; Frisch CF; Haanes EJ
Lancet; 1982 Feb; 1(8268):366-8. PubMed ID: 6120351
[TBL] [Abstract][Full Text] [Related]
37. Development of peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates.
Hou Y; Gu XX
J Immunol; 2003 Apr; 170(8):4373-9. PubMed ID: 12682274
[TBL] [Abstract][Full Text] [Related]
38. Haemophilus influenzae type b-specific antibody in infants after maternal immunization.
Englund JA; Glezen WP; Thompson C; Anwaruddin R; Turner CS; Siber GR
Pediatr Infect Dis J; 1997 Dec; 16(12):1122-30. PubMed ID: 9427456
[TBL] [Abstract][Full Text] [Related]
39. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary clearance of nontypable Haemophilus influenzae.
Hansen EJ; Toews GB
Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S69-72. PubMed ID: 2648297
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
